Air Liquide宣布收购德国家庭注入的主要球员

Air Liquide正在追求欧洲的家庭医疗活动的发展，获取最佳的医疗疗法（OMT）*，这是为德国患者提供家庭医疗保健服务的主要参与者，患有需要输注治疗的慢性疾病。

Founded in 1998,OMT, which has45名员工, provides home healthcare services for around5,000 patients和generated annual sales revenue of2013年2800万欧元。该公司被认可为其专业知识home infusion servicesthat include免疫疗法，疼痛管理, and the treatment ofpulmonary hypertension和Parkinson’s disease。其综合报价结合了规定的药物，高科技医疗设备和患者服务，使后者能够在家中而不是在医院，又促进了更大的自主权。

通过此次收购，这采用了多数股权（65％）的形式，空气液化液中加强其在德国家庭医疗保健市场的地位。2011年，本集团获得了Licher Medical Therapy (LMT)，德国领先的球员在家里的医药技术管理领域infusion therapiesfor patients suffering from帕金森病或免疫缺陷。空气已经是一个major playerin the French and Northern European infusion therapy markets.

空气液化将依靠两名创始股东的承诺以及追求OMT业务发展的团队的专业知识。必威体育网址视讯平台

Pascal Vinet, Vice-President, Healthcare Global Operations and a member of the Air Liquide Group’s Executive Committee, commented: “This acquisition strengthens our home healthcare offering and enables us to consolidate our position in the German infusion therapy market, as well as at the European level. Above all, it illustrates Air Liquide’s commitment to offering patients who suffer from chronic illnesses a service that combines innovative technologies and high added value care.“

*Optimal Medical Therapies GmbH & Co KG